-
New in the Library (January – February 2026)
Here are the latest items added to the CTN Dissemination Library for January – February 2026 (this post will be updated as new items come in): Emergency department-initiated buprenorphine for opioid use disorder: A randomized clinical trial. D’Onofrio G, et al. JAMA 2026 (in press). (Primary outcomes for CTN-0099) Investigator- and site-level outcomes of participation in an ED-based clinical trial [commentary]. Carpenter JE, et al. JAMA Network Open 2026;9(2):e2555847. (CTN-0099) Association between pregnancy intention and postpartum contraceptive interest among pregnant people with opioid use disorder. Schiff DM, et al. Journal of Substance Use and Addiction Treatment 2026 (in press). (CTN-0080) Posted on February 3, 2026, updated February 11, 2026
-
Western States Node Webinar: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (Feb 25, 2026) CME available!
Join the CTN Western States Node and the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) for their next joint webinar, February 25, 2026, 11am-12:30pm PT! In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine for people using fentanyl, including precipitated or prolonged withdrawal, patient reports that buprenorphine was ineffective, and patient preference for methadone. In response to these challenges, most clinicians surveyed reported modifying their standard induction protocols or patient counseling approaches. Clinicians treating larger patient volumes, seeing a high proportion of patients using fentanyl, or initiating treatment in non-inpatient settings were more likely to report difficulties starting patients on buprenorphine. Dr. Winstanley will present the study results and discuss their implications. 1.5 CME/CE available! For information about credit types and accreditation, as well as learning objectives for this session, download the webinar flyer. Register for the webinar here! Posted on February 11, 2026
-
Postdoc Fellowship Openings for Psychedelic/Cannabis Research at Johns Hopkins Behavioral Pharmacology Research Unit (BPRU)
The Johns Hopkins University School of Medicine invites applications for postdoctoral research fellowships at the Behavioral Pharmacology Research Unit (BPRU) within the Department of Psychiatry and Behavioral Sciences with a special focus on research related to psychedelics and/or cannabis. BPRU Fellows: Areas of Interest: Opportunities include research related to a variety of psychoactive drug classes, but the current position would be predominantly focused on research related to psilocybin, psychedelics, and/orcannabis/cannabinoids. Research projects include human behavioral pharmacology studies that utilize a variety of research methodologies including acute drug administration, cognitive and psychomotor performance, simulated driving, regulatory science, observational and naturalistic studies including ecological momentary assessment (EMA), biomarkers, and clinical trials. Funding for the position is supported by a NIDA funded T32 training grant. Eligibility: Eligible applicants for T32 slots must be a U.S. citizen or permanent resident. All applicants must have completed doctoral degree requirements (e.g., PhD, MD, DO, PsyD) prior to starting at the BPRU. Many training backgrounds are appropriate, including experimental or clinical psychology, pharmacology, toxicology, preclinical science, psychiatry or other medicine, neuroscience, nursing, public health, and social work. Prior experience with clinical trials is preferred. The BPRU is particularly interested in candidates who can contribute to the excellence of our research program. Applications from persons with disabilities, protected veterans, and persons underrepresented in science are strongly encouraged. Start date: Ideal candidate will be able to start by June 30th 2026, but other applicants will be considered. Email: BPRUpostdocprogram@jh.edu and copy Albert Garcia-Romeu (AGarci33@jhmi.edu) Posted on February 11,…
